Projects updated
IVFDaily Topics
IVFDaily My account.

Topics TextBook Just Published Webinars Journals | Office
IVFDAILY needs sponsors to support its collection of links to online education material. Encourage your suppliers and societies -
IVFDaily has developed a list of topics to reflect treads of research or publications
Each topic contains links to articles (either open-access review articles or recent publicatons) or webinars MORE
The links below are just a snapshot of publications focused on the topic. They are a starting point to explore further publications.
The list may contain open-access review articles that are in IVFDaily's permanent collection, recent publications from a variety of journals that are in IVFDailys transient collections and webinars/podcasts that are in IVFDailys permanent collection.
Use the PubMed link where available to see related or cited articles.
Access is free and undocumented. However, if you wish to keep track of which articles yor have visited, you can log on and report your activity fr CPD documentation. Visitors who view webinars within IVDaily,can record the duration of viewing and print a certificate. CLOSE
 

Ovarian stimulation. Sorted by
  ClassRoom      
Monitoring of controlled ovarian stimulation in IVF    
DOI:10.1007/s10815-024-03182-x by Journal of Assisted Reproduction and Genetics in 2024     [1024]
  TextBook      
Individualised dosing of follitropin delta affects live birth and safety in IVF: an individual participant data meta-analysis of randomised controlled trials    
DOI:10.1016/j.fertnstert.2024.05.143 by Fertility and Sterility in 2024     [854]
Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta-analysis    
DOI:10.1002/rmb2.12573 by Reproductive Medicine and Biology in 2024     [797]
Using GnRH agonists in combination with hCG in antagonist ART cycles: A SCOPING Review of recent evidences    
DOI:https://www.jbra.com.br/media/html/JBRA2377.html by JBRA Assisted Reproduction in 2023     [562]
Progestin primed ovarian stimulation, for whom, when and how?    
DOI:/10.1016/j.rbmo.2023.103639 by Reproductive BioMedicine Online in 2023     [497]
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.    
DOI:10.1002/14651858.CD005070.pub3 by Cochrane Database Syst Rev. in 2017     [166]
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).    
DOI:10.1002/14651858.CD005289.pub4 by Cochrane Database Syst Rev. in 2021     [165]
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.    
DOI:10.1186/s12958-021-00759-4 by Reproductive Biology and Endocrinology in 2021     [137]
Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis.    
DOI:10.1016/j.rbmo.2021.12.006 by Reproductive BioMedicine Online in 0     [91]
  Recent Publications      
Ovarian Stimulation Effects on Ghrelin Secretion and Reproductive Potential      
DOI:10.1111/cen.15167 by Clinical Endocrinology in 2024     [2317]
Adjuvant letrozole administration in gonadotropin releasing hormone antagonist cycles do not affect ploidy status of embryos      
DOI:10.1016/j.jogoh.2023.102689 by Journal of Gynecology Obstetrics and Human Reproduction in 2024     [2251]
Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study      
DOI:10.1186/s12958-024-01297-5 by Reproductive Biology and Endocrinology in 2024     [2153]
From patient classification to optimized treatment in ART: the AMPLITUDE Delphi consensus      
DOI:10.3389/frph.2024.1467322 by Frontiers in Reproductive Health in 2024     [2137]
Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis      
DOI:10.1371/journal.pone.0308666 by PLoS One. in 2024     [2131]
Dual trigger or hCG alone: A retrospective analysis on patients with diminished ovarian reserve under in vitro fertilization and embryo transfer (IVF-ET) treatment      
DOI:10.1016/j.ejogrb.2024.09.039 by European Journal of Obstetrics & Gynecology and Reproductive Biology in 2024     [2097]
The Additive Effect of Combinations of FSH Receptor Gene Variants in Ovarian Response to Stimulation      
DOI:10.1007/s43032-024-01700-x by Reproductive Science in 2024     [2024]
Programing the onset of ovarian stimulation: From early follicular phase start to oral contraceptive (OC) pill, to luteal phase E2, Duo-Stim and random start OS protocols      
DOI:10.1016/j.fertnstert.2024.09.011 by Fertility and Sterility in 2024     [1941]
Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study      
DOI:10.1186/s12884-024-06795-3 by BMC Pregnancy and Childbirth in 2024     [1916]
DuoStim: do we have enough evidence to use it?      
DOI:10.1016/j.fertnstert.2024.08.333 by Fertility and Sterility in 2024     [1915]
Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer      
DOI:10.1111/jog.16065 by Journal of Obstetrics and Gynaecology Research in 2024     [1897]
GnRH agonist-only trigger, compared to dual trigger, reduces oocyte retrieval rate in high responders without affecting cumulative live birth rate      
DOI:10.3389/fendo.2024.1461317 by Frontiers in Endocrinology (Lausanne) in 2024     [1864]
Exposure of antral follicles to medroxyprogesterone acetate during stimulation does not cause molecular perturbations in gonadotropin-responsiveness and steroidogenic function of granulosa cells in progestin-primed cycles      
DOI:10.1093/humrep/deae189 by Human Reproduction in 2024     [1773]
Effect of LH level on HCG trigger day on clinical outcomes in patients with diminished ovarian reserve undergoing GnRH-antagonist protocol      
DOI:10.1186/s12958-024-01280-0 by Reproductive Biology and Endocrinology in 2024     [1765]
Unexpected poor oocyte retrieval: The phenomenon of the borderline response to the Gonadotropin Releasing Hormone (GnRH) agonist trigger      
DOI:10.1016/j.xfre.2024.08.001 by F&S Reports, in 2024     [1749]
Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models      
DOI:10.1136/bmjopen-2023-079715 by BMJ Open. in 2024     [1711]
Extended versus conventional letrozole regimen in patients with polycystic ovary syndrome undergoing their first ovulation induction cycle: a prospective randomized controlled trial      
DOI:10.1093/hropen/hoae046 by Human Reproduction Open in 2024     [1605]
The good, the bad and the ugly of luteal phase stimulations      
DOI:10.1016/j.rbmo.2024.104383 by Reproductive BioMedicine Online in 2024     [1542]
Comparison of Adding Sildenafil Versus Estradiol to Clomiphene Citrate on the Applebaum Score and Pregnancy Rate in Patients With Unexplained Infertility: A Double-Blind Randomized Controlled Trial      
DOI:10.7759/cureus.63414 by Cureus. in 2024     [1532]
Can We Harvest More Mature Oocytes by Repeating Gonadotropin-Releasing Hormone Agonist Doses in Polycystic Ovarian Syndrome Patients at Risk of OHSS in Antagonist Cycles? A Randomised Clinical Trial      
DOI:10.22074/ijfs.2023.2008905.1513 by International Journal of Fertility & Sterility in 2024     [1468]
Undetected, natural conception pregnancies in luteal phase stimulations—case series and review of literature      
DOI:10.1093/humrep/deae165 by Human Reproduction in 2024     [1420]
Reproductive Outcomes of Dual Trigger versus hCG Alone in Women Undergoing In Vitro Fertilization with Fresh Embryo Transfer Cycles      
DOI:10.1155/2024/9972437 by Obstetrics and Gynecology International in 2024     [1412]
Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial      
DOI:10.1093/humrep/deae167 by Human Reproduction in 2024     [1406]
Gonadotropin-Releasing Hormone (GnRH) Agonist Protocol Improves Pregnancy Outcomes During In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatment in Young Infertile Women: A Retrospective Study      
DOI:10.7759/cureus.61554 by Cureus. in 2024     [1310]
Monitoring of controlled ovarian stimulation in IVF      
DOI:10.1007/s10815-024-03182-x by Journal of Assisted Reproduction and Genetics in 2024     [1302]
Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles      
DOI:10.1186/s13048-024-01465-6 by Journal of Ovarian Research in 2024     [1295]
Feasibility and efficacy of a subcutaneous catheter for controlled ovarian stimulation      
DOI:10.1016/j.fertnstert.2024.06.022 by Fertility and Sterility in 2024     [1282]
Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study      
DOI:10.3389/fendo.2024.1358278 by Frontiers in Endocrinology (Lausanne) in 2024     [1275]
Metagenomic analysis revealed the association between gut microbiota and different ovary responses to controlled ovarian stimulation      
DOI:10.1038/s41598-024-65869-6 by Scientific Reports in 2024     [1248]
A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial      
DOI:10.1093/humrep/deae145 by Human Reproduction in 2024     [1246]
GnRH agonist early follicular challenge test as a predictor of ovarian response in antagonist cycles for fertility preservation      
DOI:10.1038/s41598-024-65059-4 by Scientific Reports in 2024     [1201]
What protocol should not be adopted, and which patients should not be suggested double stimulation in the same ovarian cycle? A randomized controlled trial answers      
DOI:10.1093/humrep/deae141 by Human Reproduction in 2024     [1180]
BEYOND Investigators , BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle,      
DOI:10.1093/humrep/deae092 by Human Reproduction in 2024     [994]
  Webinars      
Progestin primed ovarian stimulation: for whom, when and how? An interview with Baris Ata      
RBMO Live      
New strategies to optimize ovarian stimulation for IVF/ICSI: a window to the future [IVFWW]      
IVF WorldWide      
Progestin Primed Ovarian Stimulation [IVFWW]      
IVF WorldWide      

Sub topics related to :Ovarian stimulation.
ID Course
Add-on treatment options and ART
Growth Hormone supplementation

 
 
 
 
© FertAid Pty Ltd. 2002 - 2024 - all pages. All rights reserved.
This web site is NOT intended to provide medical advice, diagnosis or treatment. Please direct all medical inquiries to your doctor.